Rizatriptan Benzoate Tablet
Product Images NDC 71335-2979

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 71335-2979). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl713352979)

Label for Rizatriptan Benzoate Tablets, USP 5 mg, by Bryant Ranch Prepack. The package contains 30 tablets. The label shows the NDC number 71335-2979-1 and includes storage instructions (20° to 25°C) and warnings to keep out of reach of children. The product is repackaged by Bryant Ranch Prepack, Inc. and manufactured by Alkem Laboratories Ltd. Two QR codes are present for GTIN and package insert.*

FDA Label Image

Rizatriptan-fig-1 (Rizatriptan Fig 1)

A line chart showing the estimated probability of response over time (hours post-dose) for Rizatriptan Benzoate 5 mg, Rizatriptan Benzoate 10 mg, and placebo. The chart compares treatment effects up to 2 hours after dosing, with Rizatriptan Benzoate showing higher response probabilities than placebo.*

FDA Label Image

Rizatriptan-fig-2 (Rizatriptan Fig 2)

A line graph showing the estimated probability of medication or rescue over 24 hours post-dose for Rizatriptan Benzoate 5 mg, Rizatriptan Benzoate 10 mg, and placebo. The x-axis represents hours post-dose, and the y-axis shows the probability percentage. Three curves illustrate comparative efficacy over time between placebo and the two dosages of Rizatriptan Benzoate.*

FDA Label Image

Rizatriptan-fig-5 (Rizatriptan Fig 5)

A line graph depicting the percentage response over time in hours post the second dose for Rizatriptan Benzoate versus placebo. The x-axis shows time points from 0.5 to 2.0 hours, and the y-axis shows percent with a 95% confidence interval. Two lines represent Rizatriptan Benzoate and placebo responses, with Rizatriptan showing consistently higher percentages than placebo.*

FDA Label Image

Rizatriptan-structure (Rizatriptan Structure)

Chemical structure of rizatriptan benzoate, showing the arrangement of atoms including a triazole ring, indole system, dimethylaminoethyl side chain, and benzoic acid moiety.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.